Hypertension in Pregnancy Clinical Trial
Official title:
Comparison Between Invasive and Non-invasive Assessment of Blood Pressure in Hypertensive Disorders of Pregnancy
NCT number | NCT04303871 |
Other study ID # | 17101032 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | December 1, 2018 |
Est. completion date | March 5, 2020 |
Verified date | March 2020 |
Source | Assiut University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Hypertensive disorders of pregnancy are important causes of maternal morbidity and mortality
worldwide. Hypertension is one of the most commonly reported health conditions among pregnant
women and complicates 5-10% of all pregnancies.(Martin et al., 2009) (Wagner et al., 2007)
The measurement of central BP in hypertensive patients became more important because of its
predictive value for cardiovascular events. Direct intra-arterial readings are considered to
be the gold standard method for blood pressure measurement but because arterial cannulation
is associated with risks, alternative non-invasive blood pressure measurements may be used.
(Araghi et al., 2006) In our study, the investigator aimed to assess the accuracy of
non-invasive central blood pressure by oscillometric automated device (Mobil O graph) in
comparison to the invasive blood pressure measurement by arterial cannulation in patients
with hypertensive disorders in pregnancy.
the investigators enrolled 100 pregnant women and 10 healthy non-pregnant women as a control
group, central blood pressure was measured invasively by arterial cannula and non-invasively
by oscillometric automated device (Mobil O Graph).
the investigatorshave found a high correlation between non-invasive central blood pressure
measurements and invasively measured both systolic (r 0.968, p=0.000) and diastolic (r 0.687,
p=0.000).
Status | Completed |
Enrollment | 117 |
Est. completion date | March 5, 2020 |
Est. primary completion date | March 1, 2020 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 50 Years |
Eligibility |
Inclusion Criteria: All Pregnant women diagnosed to have hypertensive disorders of pregnancy (chronic HTN, gestational HTN, pre-eclampsia or eclampsia) after control of hypertension using anti-hypertensive drugs. Exclusion Criteria: - Patients with previous cardiac diseases. - Chronic kidney disease (CKD) which is defined as kidney damage or glomerular filtration rate (GFR) <60 mL/min/1.73 m2 for 3 months or more, irrespective of cause. - Any disease requiring the use of anti-inflammatory medication, any other endocrine disease such as hyperthyroidism. - Conditions that prevent invasive blood pressure measurement (arterial cannulation) as severe bleeding disorders. - Patients refusing to join the study. - Any associated severe comorbidities have been excluded. |
Country | Name | City | State |
---|---|---|---|
Egypt | Assiut University Hospitals | Assiut |
Lead Sponsor | Collaborator |
---|---|
Assiut University |
Egypt,
KROEKER EJ, WOOD EH. Comparison of simultaneously recorded central and peripheral arterial pressure pulses during rest, exercise and tilted position in man. Circ Res. 1955 Nov;3(6):623-32. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | assess accuracy of non-invasive central blood pressure | to assess accuracy of non-invasive central blood pressure by oscillometric automated device (Mobil O graph) in comparison to the invasive blood pressure measurement by arterial cannulation in patients with hypertensive disorders in pregnancy | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00974714 -
L-arginine Effects on Chronic Hypertension in Pregnancy
|
Phase 3 | |
Terminated |
NCT03595982 -
Is Procardia XL 60 mg Q Daily Equivalent to 30 mg XL Given Twice Daily?
|
Phase 4 | |
Completed |
NCT04486170 -
Assessment of Postpartum Education to Improve Compliance
|
N/A | |
Completed |
NCT03506724 -
Response to Anti-hypertensives in Pregnant and Postpartum Patients
|
Phase 4 | |
Completed |
NCT03613714 -
Innovation in Postpartum Care for Women With Hypertensive Disorders of Pregnancy
|
N/A | |
Recruiting |
NCT04604535 -
The BEET-BP Trial - Investigating the Effect of Dietary Nitrates on Hypertension in Pregnancy
|
N/A | |
Completed |
NCT00412230 -
Insulin Resistance and Hypertensive Disorders in Pregnancy
|
N/A | |
Active, not recruiting |
NCT05049616 -
Oral Combined Hydrochlorothiazide/Lisinopril Versus Oral Nifedipine for Postpartum Hypertension
|
Phase 4 | |
Completed |
NCT04119232 -
Randomized Clinical Trial to Increase Physical Activity After a a Hypertensive Pregnancy
|
N/A | |
Completed |
NCT04633551 -
Vascular Inflammation and Anti-inflammatory Supplements After Adverse Pregnancy Outcomes
|
N/A | |
Completed |
NCT05859282 -
Development and Validation of a Short Tool to Assess the Awareness of Pregnancy-induced Hypertension
|
||
Active, not recruiting |
NCT05543265 -
Bridging the Gap From Postpartum to Primary Care
|
N/A | |
Completed |
NCT00571766 -
Effects of Oral L-Arginine on Chronic Hypertension in Pregnancy
|
Phase 3 | |
Recruiting |
NCT05473767 -
Expanding the Family Check-Up in Early Childhood to Promote Cardiovascular Health of Mothers and Young Children
|
N/A | |
Recruiting |
NCT05683093 -
Cardiovascular Longitudinal ALSPAC Research Investigations Following Hypertensive Pregnancy in Young Adulthood
|
||
Completed |
NCT06403722 -
Perinatal Outcomes in Patients With Elevated sFlt-1/PlGF Ratio
|
||
Recruiting |
NCT05852054 -
Supporting Transitions to Primary Care Among Under-resourced, Postpartum Women (STEP-UP)
|
Phase 3 | |
Recruiting |
NCT05137808 -
Understanding Blood Pressure Changes After Birth
|
||
Completed |
NCT03961360 -
Effectiveness of Higher Aspirin Dosing for Prevention of Preeclampsia in High Risk Obese Gravida
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT03648645 -
Hypertensive Pregnant Women Monitored by Teletransmitted Self-measurements of Blood Pressure
|
N/A |